Celia L. Carpenter

854 total citations
22 papers, 737 citations indexed

About

Celia L. Carpenter is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Celia L. Carpenter has authored 22 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Celia L. Carpenter's work include Ion channel regulation and function (15 papers), Neuroscience and Neuropharmacology Research (12 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Celia L. Carpenter is often cited by papers focused on Ion channel regulation and function (15 papers), Neuroscience and Neuropharmacology Research (12 papers) and Cardiac electrophysiology and arrhythmias (4 papers). Celia L. Carpenter collaborates with scholars based in United States, Canada and United Kingdom. Celia L. Carpenter's co-authors include David A. Greenberg, Robert O. Messing, D. Watson, Edward C. Cooper, Johann S. de Bono, Tami Yap, Ivy Fearen, Carlo Toniatti, André T. Brunetto and Alexandra Taylor and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Neurology.

In The Last Decade

Celia L. Carpenter

22 papers receiving 718 citations

Peers

Celia L. Carpenter
Francine A. Tansey United States
Klaus Rüether Germany
Sandra Siehler Switzerland
Ramanjit Gill Switzerland
Shahin Sakhi United States
Hans-Dieter Mennel Germany
Javier Sueiras-Diaz United States
Caroline Nunn Switzerland
Hiroshi Fushiki Japan
Sooyeon Jo United States
Francine A. Tansey United States
Celia L. Carpenter
Citations per year, relative to Celia L. Carpenter Celia L. Carpenter (= 1×) peers Francine A. Tansey

Countries citing papers authored by Celia L. Carpenter

Since Specialization
Citations

This map shows the geographic impact of Celia L. Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Celia L. Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Celia L. Carpenter more than expected).

Fields of papers citing papers by Celia L. Carpenter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Celia L. Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Celia L. Carpenter. The network helps show where Celia L. Carpenter may publish in the future.

Co-authorship network of co-authors of Celia L. Carpenter

This figure shows the co-authorship network connecting the top 25 collaborators of Celia L. Carpenter. A scholar is included among the top collaborators of Celia L. Carpenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Celia L. Carpenter. Celia L. Carpenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yap, Tami, Libo Yan, David Olmos, et al.. (2011). Final results of a translational phase l study assessing a QOD schedule of the potent AKT inhibitor MK-2206 incorporating predictive, pharmacodynamic (PD), and functional imaging biomarkers.. Journal of Clinical Oncology. 29(15_suppl). 3001–3001. 9 indexed citations
3.
Schelman, William R., Shahneen Sandhu, Víctor Moreno, et al.. (2011). First-in-human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients with antitumor activity in BRCA-deficient tumors and sporadic ovarian cancers (soc).. Journal of Clinical Oncology. 29(15_suppl). 3102–3102. 42 indexed citations
4.
5.
Tolcher, Anthony W., Tami Yap, Ivy Fearen, et al.. (2009). A phase I study of MK-2206, an oral potent allosteric Akt inhibitor (Akti), in patients (pts) with advanced solid tumor (ST). Journal of Clinical Oncology. 27(15_suppl). 3503–3503. 54 indexed citations
6.
7.
Watson, D., et al.. (1989). Calcium channel antagonist receptors in cerebral cortex from alcoholic patients. Brain Research. 478(1). 196–198. 16 indexed citations
8.
Carpenter, Celia L., et al.. (1988). Dextromethorphan and dextrorphan as calcium channel antagonists. Brain Research. 439(1-2). 372–375. 102 indexed citations
9.
Watson, D., et al.. (1988). Striatal calcium channel antagonist receptors in huntington's disease and parkinson's disease. Annals of Neurology. 23(3). 303–305. 18 indexed citations
10.
Greenberg, David A., Celia L. Carpenter, & Robert O. Messing. (1987). Lectin‐Induced Enhancement of Voltage‐Dependent Calcium Flux and Calcium Channel Antagonist Binding. Journal of Neurochemistry. 48(3). 888–894. 13 indexed citations
11.
Greenberg, David A., Celia L. Carpenter, & Robert O. Messing. (1987). Ethanol-induced component of 45Ca2+ uptake in PC12 cells is sensitive to Ca2+ channel modulating drugs. Brain Research. 410(1). 143–146. 54 indexed citations
12.
Greenberg, David A., Celia L. Carpenter, & Robert O. Messing. (1987). Calcium channel antagonist properties of the antineoplastic antiestrogen tamoxifen in the PC12 neurosecretory cell line.. PubMed. 47(1). 70–4. 67 indexed citations
13.
Greenberg, David A., Celia L. Carpenter, & Robert O. Messing. (1986). Depolarization-dependent binding of the calcium channel antagonist, (+)-[3H]PN200-110, to intact cultured PC12 cells.. Journal of Pharmacology and Experimental Therapeutics. 238(3). 1021–1027. 34 indexed citations
14.
Messing, Robert O., Celia L. Carpenter, & David A. Greenberg. (1986). Inhibition of calcium flux and calcium channel antagonist binding in the PC12 neural cell line by phorbol esters and protein kinase C. Biochemical and Biophysical Research Communications. 136(3). 1049–1056. 43 indexed citations
15.
Messing, Robert O., Celia L. Carpenter, & David A. Greenberg. (1985). Mechanism of calcium channel inhibition by phenytoin: comparison with classical calcium channel antagonists.. Journal of Pharmacology and Experimental Therapeutics. 235(2). 407–411. 60 indexed citations
16.
Greenberg, David A., Edward C. Cooper, & Celia L. Carpenter. (1985). Reversible Dihydropyridine Isothiocyanate Binding to Brain Calcium Channels. Journal of Neurochemistry. 44(1). 319–321. 3 indexed citations
17.
Greenberg, David A., Celia L. Carpenter, & Edward C. Cooper. (1985). Stimulation of Calcium Uptake in PC12 Cells by the Dihydropyridine Agonist BAY K 8644. Journal of Neurochemistry. 45(3). 990–993. 32 indexed citations
18.
Greenberg, David A., Edward C. Cooper, & Celia L. Carpenter. (1984). Calcium entry activators: Distinct sites of dihydropyridine and aminopyridine action. Neuroscience Letters. 50(1-3). 279–282. 2 indexed citations
19.
Greenberg, David A., Edward C. Cooper, & Celia L. Carpenter. (1984). Phenytoin interacts with calcium channels in brain membrances. Annals of Neurology. 16(5). 616–617. 29 indexed citations
20.
Greenberg, David A., Edward C. Cooper, & Celia L. Carpenter. (1984). Calcium channel ‘agonist’ BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes. Brain Research. 305(2). 365–368. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francine A. Tansey Breakdown of academic impact, for papers by Klaus Rüether Breakdown of academic impact, for papers by Sandra Siehler Breakdown of academic impact, for papers by Ramanjit Gill Breakdown of academic impact, for papers by Shahin Sakhi Breakdown of academic impact, for papers by Hans-Dieter Mennel Breakdown of academic impact, for papers by Javier Sueiras-Diaz Breakdown of academic impact, for papers by Caroline Nunn Breakdown of academic impact, for papers by Hiroshi Fushiki Breakdown of academic impact, for papers by Sooyeon Jo
Rankless by CCL
2026